Blog: CRYOMASS TECHNOLOGIES, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 20, 2022, Cryomass Technologies Inc (the “Company”) held its Annual
Meeting of Stockholders (the “Annual Meeting”). As of the close of business of
April 29, 2022, the record date for the Annual Meeting, 200,435,331 common
shares of the Company stock were outstanding and entitled to vote at the Annual
Meeting. At the Annual Meeting, 117,755,757 shares representing approximately
58.75% of the outstanding common shares entitled to vote, were represented in
person or by proxy and, therefore, a quorum was present pursuant to the
Company’s Bylaws, which require 1% of the outstanding common shares entitled to
vote to be present in order to meet quorum requirements.

The stockholders of the Company voted on the following items at the Annual
Meeting:

1. A proposal to elect five directors, namely Messrs. Delon Human, Mark Radke,

     Mario Gobbo, Simon Langelier and Christian Noël to serve until the next
     annual meeting of stockholders and until their respective successors are duly
     elected and qualified;


2. A proposal to ratify the appointment of BF Borgers, CPA PC as the Company’s

independent registered public accounting firm for the fiscal year ending

December 31, 2022;

3. A proposal to grant the Board of Directors the discretionary authority to

    amend the Company's articles of incorporation to effect a reverse stock split
    (the "Reverse Split Proposal") of the Company's common stock (the "Common
    Stock");



For more information about the foregoing proposals, see the Company’s definitive
proxy statement filed on, 2022.

Set forth below are the voting results with respect to the foregoing proposals.

1. A proposal to elect five directors, namely Messrs. Delon Human, Mark Radke,

Mario Gobbo, Simon Langelier and Christian Noël to serve until the next annual

meeting of stockholders and until their respective successors are duly elected

    and qualified.




Dr Delon Human



FOR:       104,862,998 shares
AGAINST:   57,987 shares
ABSTAIN:   21, 965 shares




Mr. Mark Radke



FOR:       104,760,633
AGAINST:   156,856
ABSTAIN:   125,461




Mr. Mario Gobbo



FOR:       104,757,898
AGAINST:   159,356
ABSTAIN:   125,696




Mr. Simon Langelier



FOR:       104,936,073
AGAINST:   84,781
ABSTAIN:   22,096




Mr. Christian Noël



FOR:       104,936,073
AGAINST:   84,781
ABSTAIN:   22,096



Based on the votes set forth above, the director nominees were duly elected.



                                       1




2. A proposal to ratify the appointment of BF Borgers, CPA PC as the Company’s

    independent registered public accounting firm for the fiscal year ending
    December 31, 2022.




FOR:       117,289,763 shares

AGAINST:   88,569 shares

ABSTAIN:   203,445 shares



Based on the votes set forth above, the appointment of BF Borgers, CPA PC as the
Company’s independent registered public accounting firm for the fiscal year
ending December 31, 2022, was duly ratified.

3. A proposal to grant the Board of Directors the discretionary authority to

    amend the Company's articles of incorporation to effect a reverse stock split
    (the "Reverse Split Proposal") of the Company's common stock (the "Common
    Stock").




FOR:       113,506,568 shares

AGAINST:   996,130 shares

ABSTAIN:   3,259,080 shares




Based on the votes set forth above, the Board of Directors was duly granted the
discretionary authority to amend the Company’s articles of incorporation to
effect the Reverse Split Proposal of the Common Stock.

Item 7.01. Regulation FD Disclosure.

On June 20, 2022, during the Annual Meeting of the Stockholders of the Company,
the Chief Executive Officer of the Company, Mr. Christian Noël, provided verbal
remarks. A transcript of his remarks is furnished as Exhibit 99.1 to this report
and incorporated herein by reference.

The information in Item 7.01 of this Current Report and Exhibit 99.1 is being
furnished, not filed, pursuant to Items 7.01 and 9.01 of Form 8-K. Accordingly,
the information in Items 7.01 and 9.01 of this Current Report, including Exhibit
99.1, will not be subject to liability under Section 18 of the Securities and
Exchange Act of 1934, as amended (the “Exchange Act”), and will not be
incorporated by reference into any registration statement or other document
filed by the Company under the Securities Act of 1933, as amended, or the
Exchange Act, unless specifically identified therein as being incorporated by
reference. The furnishing of information in this Current Report, including
Exhibit 99.1, is not intended to, and does not, constitute a determination or
admission by the Company that the information in this Current Report, including
Exhibit 99.1, is material or complete, or that investors should consider this
information before making an investment decision with respect to any security of
the Company or any of its affiliates.



                                       2

Item 9.01. Financial Statements and Exhibits.



EXHIBIT 99.1     Remarks of Cryomass Technologies Inc CEO, Mr. Christian Noël, at
               the June 20, 2022 Annual Meeting of Stockholders of the Company
104            Cover Page Interactive Data File (embedded within the Inline XBRL
               document)



NOTE REGARDING FORWARD LOOKING STATEMENTS

Any statements in this Current Report on Form 8-K or any exhibit hereto about
future expectations, plans, and prospects for the Company, including statements
about Company’s future expectations, beliefs, goals, plans, or prospects,
constitute “forward-looking statements” within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act. In some cases you can
identify forward-looking statements because they contain words such as
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,”
“may,” “might,” “likely,” “plan,” “potential,” “predict,” “project,” “seek,”
“should,” “target,” “will,” “would,” or similar expressions and the negatives of
those terms.

These forward-looking statements involve risks, uncertainties, and assumptions
that could cause actual performance or results to differ materially from those
expressed or suggested by the forward-looking statements. If any of these risks
or uncertainties materialize, or if any of Company’s assumptions prove
incorrect, its actual results could differ materially from the results expressed
or implied by these forward-looking statements. These risks and uncertainties
include risks associated with: Company’s ability to achieve or maintain
profitability, and to effectively manage its anticipated growth; and the risks
described in the other filings Company makes with the Securities and Exchange
Commission from time to time, including the risks described under the heading
“Risk Factors” in Company’s Annual Report on Form 10-K for the year ended
December 31, 2020 and subsequent quarterly reports on Form 10-Q, and which
should be read in conjunction with its financial results and forward-looking
statements. All forward-looking statements in this Current Report on Form 8-K or
any exhibit hereto are based on information available to Company as of the date
hereof, and it does not assume any obligation to update the forward-looking
statements provided to reflect events that occur or circumstances that exist
after the date on which they were made, except as required by law.




                                       3

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s